Surgical Oncology, the NRG-HN006 trial for early-stage oral cavity cancer, and patient language in protocols with Dr. Lai
Release Date:
Drs. Chun and Henke sit down with Dr. Stephen Lai, the NRG Oncology Surgical Oncology Committee Chair and the PI of the NRG-HN006 study of sentinel lymph node biopsy for early stage oral cavity disease. Dr. Lai addresses how surgical oncology fits within the NRG spectrum, his very important study that is actively enrolling patients, and his advocacy and passion for improving patient language on protocol documents.
Surgical Oncology, the NRG-HN006 trial for early-stage oral cavity cancer, and patient language in protocols with Dr. Lai